Table 6 Responder rates (%) according to weekly incontinence episodes by cause of FI (ITT)
From: Skeletal muscle-derived cell implantation for the treatment of sphincter-related faecal incontinence
|  | Muscle damage (N = 16) | Atrophy (N = 17) | Both (N = 6) | ||||||
|---|---|---|---|---|---|---|---|---|---|
V2 | V3 | V4 | V2 | V3 | V4 | V2 | V3 | V4 | |
R(0–19) | 25.0 | 12.5 | 12.5 | 5.9 | 11.8 | 11.8 | 16.7 | 0.0 | 0.0 |
R(20–49) | 31.3 | 18.8 | 25.0 | 29.4 | 11.8 | 0.0 | 66.7 | 33.3 | 0.0 |
R(50–99) | 43.8 | 56.3 | 50.0 | 52.9 | 58.8 | 70.6 | 16.7 | 66.7 | 83.3 |
R(100) | 0.0 | 12.5 | 12.5 | 11.8 | 17.6 | 17.6 | 0.0 | 0.0 | 16.7 |